United States · Wires & real time · PR Newswire

New clinical data on lecanemab to be presented at CTAD conference 2026

Published by PR Newswire · United States 1 h ago

STOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

What to consider if a company that made AI-related job cuts wants you back

Business Wire

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Dow Jones Newswires

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires

New clinical data on lecanemab to be presented at CTAD conference 2026

Share

Also worth reading

What to consider if a company that made AI-related job cuts wants you back

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows